Case of de novo psoriasis possibly triggered by nivolumab

Journal of Dermatology

Volumn 44, Issue 1, 2017, Pages 99-100

  Murata, Susumu ^a   Kaneko, Sakae ^a   Harada, Yuji ^a   Aoi, Noriaki ^a   Morita, Eishin ^a  

^a SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; NIVOLUMAB; ANTINEOPLASTIC AGENT; BETAMETHASONE; BETAMETHASONE DIPROPIONATE, CALCIPOTRIOL DRUG COMBINATION; CALCITRIOL; DRUG COMBINATION; MONOCLONAL ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR;

AGED; AMELANOTIC MELANOMA; CACHEXIA; CASE REPORT; DEATH; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHEMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; LETTER; MALE; METASTATIC MELANOMA; PARAKERATOSIS; PRURITUS; PSORIASIS VULGARIS; VERY ELDERLY; VITILIGO; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CANCER STAGING; CHEMICALLY INDUCED; CUTANEOUS DRUG ADMINISTRATION; DRUG COMBINATION; IMMUNOLOGY; MELANOMA; METABOLISM; PATHOLOGY; PSORIASIS; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TUMOR RECURRENCE;

ADMINISTRATION, CUTANEOUS; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BETAMETHASONE; CALCITRIOL; DRUG COMBINATIONS; HUMANS; MALE; MELANOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGRAMMED CELL DEATH 1 RECEPTOR; PSORIASIS; SIGNAL TRANSDUCTION; TH1 CELLS; TH17 CELLS;

EID: 84969922454     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.13450     Document Type: Letter

References (5)

1. Ohtsuka M, Miura T, Mori T, Ishikawa M, Yamamoto T. Occurrence of psoriasiform eruption during nivolumab therapy for primary oral mucosal melanoma. JAMA Dermatol 2015; 151: 797–799.
2. Matsumura N, Ohtsuka M, Kikuchi N, Yamamoto T. Exacerbation of psoriasis during nivolumab therapy for metastatic melanoma. Acta Derm Venereol 2016; 96: 259–260.
3. Kato Y, Otsuka A, Miyachi Y, Kabashima K. Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma. J Eur Acad Dermatol Venereol 2016; 30: e89–e91.
4. Nakayama J, Qing X, Ozawa A et al. Comparative epidemiological studies on hyperlipidemia and HLA typing between Japanese and Chinese psoriatic patients. Jpn J Dermatol 1995; 105: 1743–1751. (In Japanese).
5. Arakawa A, Siewert K, Stöhr J et al. Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med 2015; 212: 2203–2212.